Immunome IMNM
NASDAQ IMNM
$17.86 -0.14 (-0.78%)
As of: Oct 22, 2026 · 10:17 AM EDT

Immunome (IMNM) Ending Cash Balance (2019 - 2025)

Updated

Analysis

Immunome (IMNM) Ending Cash Balance (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,164.71 Bn 1,133.30 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 633.37 Bn 551.90 Bn 17.26 Bn 20.42 Bn
3 AbbVie 503.99 Bn 477.10 Bn 12.70 Bn 6.57 Bn
4 Merck 378.19 Bn 332.57 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 303.15 Bn 267.14 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 266.17 Bn 239.85 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.38 Bn 196.78 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn 1.03 Bn
10 Immunome 2.03 Bn 2.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 653.69 Mn
Dec 31, 2024 143.45 Mn
Dec 31, 2023 98.78 Mn
Dec 31, 2022 20.42 Mn
Mar 31, 2021 36.38 Mn
Dec 31, 2020 39.87 Mn
Sep 30, 2020 6.84 Mn
Mar 31, 2020 1.37 Mn
Dec 31, 2019 2.64 Mn
Sep 30, 2019 860,000.00
API Access

Immunome Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=IMNM&period=max&api_key=YOUR_API_KEY